In addition, immunohistochemistry results suggested that there were no statistically significant correlations between the percentage of patients with PSMA-positive NECs or/and tumor cells and gender, pathological type of NSCLC, size of primary tumor, or presence or absence of lymph node metastasis (Table 1). This evidence concerns the gene FOLH1 and non-small cell lung carcinoma.